Atipamezole

Compendium: Continuing Education For Veterinarians

Volumn 30, Issue 5, 2008, Pages 256-258

  Bahri, Lotfi El ^a  

^a Ecole Nationale de Medecine Veterinaire   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; IMIDAZOLE DERIVATIVE; VETERINARY DRUG;

ANESTHESIA; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOSE RESPONSE; DRUG LEGISLATION; LD 50; PHYSIOLOGY;

ADRENERGIC ALPHA-ANTAGONISTS; ANESTHESIA; ANIMALS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; LEGISLATION, DRUG; LETHAL DOSE 50; VETERINARY DRUGS;

EID: 46649114142     PISSN: 19408307     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The Merck Index. An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th ed. Whitehouse Station, NJ: Merck & Co; 2001:148.
2. Plumb DC. Atipamezole. Veterinary Drug Handbook. 4th ed. Ames, IA: Iowa State University Press; 2002:76-77.
3. Ranheim B, Soli NE, Ryeng KA, et al. Pharmacokinetics of medetomidine and atipamezole in dairy calves: an agonist-antagonist interaction. J Vet Pharmacol Ther 1998;21(6):428-432.
4. Versiegen J, Fargetton X, Zanker S, et al. Antagonistic activities of atipamezole, 4-aminopyridine and yohimbine against medetomidine/ketamineinduced anaesthesia in cats. Vet Rec 1991;128(3):57-60.
5. Scheinin H. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha 2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology 1998;89(3):574-584.
6. Schwartz DD, Clark TP Selectivity of atipamezole, yohimbine and tolazolidine for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep. J Vet Pharmacol Ther-1998;21(6):342-347.
7. Andrade SF, Sakate M, Laposy CB, et al. Yohimbine and atipamezole on the treatment of experimentally induced amitraz intoxication in cats, Int J Appl Res Vet Med 2006;4(3):200-208.
8. Product information. Antisedan (atipamezole hydrochloride). New York: Pfizer Animal Health; 2006.
9. Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res 2004;61:1-48.
10. Hugnet C, Berny P, Lorgue G. Observations cliniques d'intoxication du chien par l'amitraze: intérèt de l'atipamezole (Antisédan®) dans le traitement. Revue Méd Vét 1995;146(2):85-88.
11. 2-adrenoceptor antagonist [3H] atipamezole. Eur J Pharmacol 1992;224(2):27-38.
12. Goldberg MR, Robertson D. Yohimbine: a pharmacological probe for study of the alpha 2-adrenorecepror. Pharmacol Rev 1983;35(2):143-180.
13. Lemke KA. Perioperative use of selective alpha-2 agonists and antagonists in small animals. Can Vet J 2004;45(6):475-480.
14. Hsu WH, Kakuk TJ. Effect of amitraz and chlordimeform on heart rate and pupil diameter in rats mediated by alpha-2 adrenoreceptors. Toxicol Appl Pharmacol 1994;73(33):411-415.
15. 2- adrenoreceptor agonists in the brain. Acta Vet Scand 1986;(82):35-46.
16. Virtanen R, Savola JM, Saano V. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole. Arch Int Pharmacodyn Ther 1989;297:190-204.
17. Jolkkonen J, Puurunen K, Rantakömi S, et al. Behavorial effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Eur J Pharmacol 2000;(400):211-219.
18. Pertovaara A, Haapalinna A, Sirviö J, et al. Pharmacological properties, cen tral nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist. CNS Drug Rec. 2005;11(3):273-288.
19. Ko JCH, Fox SM, Mandsager RE. Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs.JAVMA 2000;216(10):1578-1583.
20. Dart RC. Antidotes: The 5-Minute Toxicology Consult. Philadelphia: Lippincott Williams & Willems; 2000:436-437.
21. American Society for the Prevention of Cruelty to Animals Animal Poison Control Center. Newsletter: Veterinary Lifeline Partner Program. September 2006.
22. Andrade SF, Sakate M.The comparative efficacy of yohimbine and atipamezole to treat amitraz intoxication in dogs. Vet Hum Toxicol 2003;45(3):124-127.
23. 2-Antagonists. In: Tranquilli WJ, Thurmon JC, Grimm KA. eds. Lumb & Jones Veterinary Anesthesia and Analgesia. 4th ed. Ames, IA: Blackwell Publishing; 2007:225-227.
24. Väha-Vahe T. The clinical effectiveness of atipamezole as a medetomidine antagonist in the dog. J Vet Pharmacol Ther 1990;13(2):198-205.
25. Vainio O. Reversal of medetomidine-induced cardiovascular and respiratory changes with atipamezole in dogs. Vet Rec 1990;127(18):447-450.
26. Plumb DC. Amitraz. Veterinary Drug Handbook. 4th ed. Ames, IA: Iowa State University Press; 2002:35-36.
27. Hugnet C, Buronfosse T, Keck G, et al. Intoxication par l'Amitraze chez les carnivores domestiques. Revue Méd Vét 1995;171(2/3):143-147.